Avatar
Fat8beetle

0 Following 0 Followers
1
T and persistent Ab responses to beta-amyloid; the Ab response wasT and persistent Ab responses to beta-amyloid; the Ab response was characterized by a marked prevalence of IgG1 over the IgG2a isotype Ref. [65]BS1-EMimotope 1 from HIV-1 bridging sheet domain (BS) HIV-1 SF162 Env V3 loop peptide 291-336 from gp120 (HXB2 numbering) HIV-1 SF162 Env MPER peptide 649-689 from gp41 (HXB2 numbering
1
T and persistent Ab responses to beta-amyloid; the Ab response wasT and persistent Ab responses to beta-amyloid; the Ab response was characterized by a marked prevalence of IgG1 over the IgG2a isotype Ref. [65]BS1-EMimotope 1 from HIV-1 bridging sheet domain (BS) HIV-1 SF162 Env V3 loop peptide 291-336 from gp120 (HXB2 numbering) HIV-1 SF162 Env MPER peptide 649-689 from gp41 (HXB2 numbering
1
Ng process and process controls have been developed, although [43] all theNg process and process controls have been developed, although [43] all the methods share a common general procedure . Liposome formulations with optimized properties - such as high stability, long blood circulation half-life (GM glycolipidWJV|www.wjgnet.comAugust 12, 2015|Volume 4|Issue 3|Trovato M et al . Vaccine deli
1
Ng process and process controls have been developed, although [43] all theNg process and process controls have been developed, although [43] all the methods share a common general procedure . Liposome formulations with optimized properties - such as high stability, long blood circulation half-life (GM glycolipidWJV|www.wjgnet.comAugust 12, 2015|Volume 4|Issue 3|Trovato M et al . Vaccine deli
1
Major capsid protein L1 produced in S. cerevisiae. In 2009 the FDAMajor capsid protein L1 produced in S. cerevisiae. In 2009 the FDA approved Cervarix, a bivalent (HPV types 16 and 18) vaccine commercialized by GlaxoSmithKline (GSK). Both the HPV VLP vaccines have shown to have a sustained prophylactic efficacy in clinical trials against infection and genital disease, generating a long-lasti
1
Cular, intradermal, intranasal, vaginal routes); they ensure a rapid uptake ofCular, intradermal, intranasal, vaginal routes); they ensure a rapid uptake of the delivered molecule by immune cells (APCs and B cells), for MHC class I and class II presentation. Heterologous antigens exposed on the surface primarily evoke humoral immune responses, while the encapsulation approach give rise to CT
1
Cular, intradermal, intranasal, vaginal routes); they ensure a rapid uptake ofCular, intradermal, intranasal, vaginal routes); they ensure a rapid uptake of the delivered molecule by immune cells (APCs and B cells), for MHC class I and class II presentation. Heterologous antigens exposed on the surface primarily evoke humoral immune responses, while the encapsulation approach give rise to CT
1
Large structural scaffold formed by the multi-domain core enzyme, E2, aLarge structural scaffold formed by the multi-domain core enzyme, E2, a specific dihydrolipoyl acetyltransferase. The E2 polypeptide chain is composed of three independently folded domains separated by flexible linker regions: a lypoil domain (LD) of 9.5 kDa, a peripheral (E1 and/or E3) subunit-binding domain (PSBD) of 5.